RxDoctor Payments Data

Daniel Blizzard, DO

Family Medicine · Ocean Isle Beach, NCNPI 1437194354

Payments from drug & device makers

$1,164in general payments, 2019–2025

Across 47 payments — averaging $24.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$513
  • Lilly USA, LLC$159
  • Alphatec Spine, Inc$147
  • Amgen$90
  • Globus Medical$59
  • Pfizer$58
  • plus $137 from 8 others

What the payments were for

  • Food & beverage$1,164100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,164 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$72,785
Medicare patients
98
Services billed
1,722

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide39$36,754
EliquisApixaban17$24,335
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$9,310
Atorvastatin Calcium236$2,840
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl12$2,368
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$2,330
Testosterone11$1,532
Ezetimibe22$1,085
Gabapentin79$1,013
Metoprolol Succinate44$864
Omeprazole58$802
Metformin Hcl103$797
Tamsulosin Hcl28$738
Esomeprazole Magnesium31$727
Memantine Hcl32$700

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Insulin Lispro$159$37,36651 claims
PfizerEliquis$58$24,33517 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Ocean Isle Beach

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →